Tyrphostin A51 is a potent protein tyrosine kinase (PTK) inhibitor; it inhibits volume-dependent release of [3H]taurine in a dose-dependent manner; significantly reduces cellular tyrosyl phosphorylation levels; and inhibits both basal and EGF-induced proliferation of human osteoblasts.